370 related articles for article (PubMed ID: 21711087)
1. Recent progress in therapeutic applications of chalcones.
Katsori AM; Hadjipavlou-Litina D
Expert Opin Ther Pat; 2011 Oct; 21(10):1575-96. PubMed ID: 21711087
[TBL] [Abstract][Full Text] [Related]
2. Coumarin-based drugs: a patent review (2008 -- present).
Kontogiorgis C; Detsi A; Hadjipavlou-Litina D
Expert Opin Ther Pat; 2012 Apr; 22(4):437-54. PubMed ID: 22475457
[TBL] [Abstract][Full Text] [Related]
3. Coumarin derivatives: an updated patent review (2012-2014).
Katsori AM; Hadjipavlou-Litina D
Expert Opin Ther Pat; 2014 Dec; 24(12):1323-47. PubMed ID: 25327901
[TBL] [Abstract][Full Text] [Related]
4. Coumarin derivatives: an updated patent review (2015-2016).
Detsi A; Kontogiorgis C; Hadjipavlou-Litina D
Expert Opin Ther Pat; 2017 Nov; 27(11):1201-1226. PubMed ID: 28756713
[TBL] [Abstract][Full Text] [Related]
5. Potential pharmacological uses of chalcones: a patent review (from June 2011 - 2014).
Matos MJ; Vazquez-Rodriguez S; Uriarte E; Santana L
Expert Opin Ther Pat; 2015 Mar; 25(3):351-66. PubMed ID: 25598152
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents.
Bandgar BP; Gawande SS; Bodade RG; Totre JV; Khobragade CN
Bioorg Med Chem; 2010 Feb; 18(3):1364-70. PubMed ID: 20064725
[TBL] [Abstract][Full Text] [Related]
7. Recent development on naphthoquinone derivatives and their therapeutic applications as anticancer agents.
Tandon VK; Kumar S
Expert Opin Ther Pat; 2013 Sep; 23(9):1087-108. PubMed ID: 23651032
[TBL] [Abstract][Full Text] [Related]
8. Chalcones and their potential role in inflammation.
Kontogiorgis C; Mantzanidou M; Hadjipavlou-Litina D
Mini Rev Med Chem; 2008 Oct; 8(12):1224-42. PubMed ID: 18855737
[TBL] [Abstract][Full Text] [Related]
9. The design and development of imidazothiazole-chalcone derivatives as potential anticancer drugs.
Kamal A; Kashi Reddy M; Viswanath A
Expert Opin Drug Discov; 2013 Mar; 8(3):289-304. PubMed ID: 23317445
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of boswellic acids: a patent review (1990-2015).
Hussain H; Al-Harrasi A; Csuk R; Shamraiz U; Green IR; Ahmed I; Khan IA; Ali Z
Expert Opin Ther Pat; 2017 Jan; 27(1):81-90. PubMed ID: 27646163
[TBL] [Abstract][Full Text] [Related]
11. Indazole derivatives and their therapeutic applications: a patent review (2013-2017).
Denya I; Malan SF; Joubert J
Expert Opin Ther Pat; 2018 Jun; 28(6):441-453. PubMed ID: 29718740
[TBL] [Abstract][Full Text] [Related]
12. Novel benzopyran derivatives and their therapeutic applications: a patent review (2009-2016).
Xiu C; Hua Z; Xiao BS; Tang WJ; Zhou HP; Liu XH
Expert Opin Ther Pat; 2017 Sep; 27(9):1031-1045. PubMed ID: 28627270
[TBL] [Abstract][Full Text] [Related]
13. Chalcones in cancer: understanding their role in terms of QSAR. II part.
Repanas A; Katsori AM; Hadjipavlou-Litina D
Mini Rev Med Chem; 2013 Jun; 13(7):952-70. PubMed ID: 22876949
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents.
Bandgar BP; Gawande SS
Bioorg Med Chem; 2010 Mar; 18(5):2060-5. PubMed ID: 20138527
[TBL] [Abstract][Full Text] [Related]
15. Berberine and its derivatives: a patent review (2009 - 2012).
Singh IP; Mahajan S
Expert Opin Ther Pat; 2013 Feb; 23(2):215-31. PubMed ID: 23231038
[TBL] [Abstract][Full Text] [Related]
16. Curcumin analogues and derivatives with anti-proliferative and anti-inflammatory activity: Structural characteristics and molecular targets.
Chainoglou E; Hadjipavlou-Litina D
Expert Opin Drug Discov; 2019 Aug; 14(8):821-842. PubMed ID: 31094233
[No Abstract] [Full Text] [Related]
17. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
18. The development of chalcones as promising anticancer agents.
Ducki S
IDrugs; 2007 Jan; 10(1):42-6. PubMed ID: 17187314
[TBL] [Abstract][Full Text] [Related]
19. Secondary and tertiary sulfonamides: a patent review (2008 - 2012).
Scozzafava A; Carta F; Supuran CT
Expert Opin Ther Pat; 2013 Feb; 23(2):203-13. PubMed ID: 23148584
[TBL] [Abstract][Full Text] [Related]
20. Quinazoline derivatives as anticancer drugs: a patent review (2011 - present).
Ravez S; Castillo-Aguilera O; Depreux P; Goossens L
Expert Opin Ther Pat; 2015 Jul; 25(7):789-804. PubMed ID: 25910402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
